iShares Biotechnology ETF (IBB)

iShares Biotechnology ETF (IBB $174.98)
- $174.98 P/E (TTM): 20.63X Cap: $8.66B
- View IBB Profile
- View Questions on IBB

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $488.15)
- $488.15 P/E (TTM): 62.92X Cap: $173.35B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $477.92)
- $477.92 P/E (TTM): 32.08X Cap: $121.25B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $223.43)
- $223.43 P/E (TTM): 167.19X Cap: $394.88B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $239.99)
- $239.99 P/E (TTM): 22.95X Cap: $578.20B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $1,058.18)
- $1,058.18 P/E (TTM): 49.94X Cap: $1T
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $121.93)
- $121.93 P/E (TTM): 15.83X Cap: $302.63B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $174.98)
- $174.98 P/E (TTM): 20.63X Cap: $8.66B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $644.61)
- $644.61 P/E (TTM): 51.04X Cap: $51.47B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $81.23)
- $81.23 P/E (TTM): 16.51X Cap: $9.55B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $108.39)
- $108.39 P/E (TTM): 17.57X Cap: $21.27B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $24.44)
- $24.44 P/E (TTM): 13.9X Cap: $3B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $31.27)
- $31.27 P/E (TTM): 393.08X Cap: $258.69B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026

iShares Biotechnology ETF (IBB $174.98)
- $174.98 P/E (TTM): 20.63X Cap: $8.66B
- View IBB Profile
- View Questions on IBB
State Street SPDR S&P Biotech ETF (XBI $125.51)
- $125.51 P/E (TTM): 17.26X Cap: $8.38B
- View XBI Profile
- View Questions on XBI
Natera Inc. (NTRA $203.04)
- $203.04 Cap: $28.08B
- View NTRA Profile
- View Questions on NTRA
ARK Genomic Revolution ETF (ARKG $28.79)
- $28.79 P/E (TTM): 41.03X Cap: $1.10B
- View ARKG Profile
- View Questions on ARKG
Catalyst Pharmaceuticals Inc. (CPRX $24.44)
- $24.44 P/E (TTM): 13.9X Cap: $3B
- View CPRX Profile
- View Questions on CPRX

Q: It looks like biotech stocks are on a tear, especially those that may benefit from AI. Do you have any names that you might recommend? I'm considering the Arkg fund but I don't quite trust Cathy Woods after losing money on the Arkk fund in 2021. Thank you,

Jason

Read Answer Asked by Jason on February 18, 2025

Biogen Inc. (BIIB $201.18)
- $201.18 P/E (TTM): 16.91X Cap: $29.51B
- View BIIB Profile
- View Questions on BIIB
Gilead Sciences Inc. (GILD $152.50)
- $152.50 P/E (TTM): 23.12X Cap: $189.20B
- View GILD Profile
- View Questions on GILD
Illumina Inc. (ILMN $119.72)
- $119.72 P/E (TTM): 30.79X Cap: $18.29B
- View ILMN Profile
- View Questions on ILMN
AbbVie Inc. (ABBV $223.43)
- $223.43 P/E (TTM): 167.19X Cap: $394.88B
- View ABBV Profile
- View Questions on ABBV
Abbott Laboratories (ABT $110.83)
- $110.83 P/E (TTM): 13.69X Cap: $192.71B
- View ABT Profile
- View Questions on ABT
Eli Lilly and Company (LLY $1,058.18)
- $1,058.18 P/E (TTM): 49.94X Cap: $1T
- View LLY Profile
- View Questions on LLY
Novo Nordisk A/S (NVO $47.64)
- $47.64 P/E (TTM): 12.31X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
iShares Biotechnology ETF (IBB $174.98)
- $174.98 P/E (TTM): 20.63X Cap: $8.66B
- View IBB Profile
- View Questions on IBB
State Street SPDR S&P Biotech ETF (XBI $125.51)
- $125.51 P/E (TTM): 17.26X Cap: $8.38B
- View XBI Profile
- View Questions on XBI
First Trust NYSE Arca Biotechnology ETF (FBT $37.03)
- $37.03 P/E (TTM): 22.51X Cap: $1M
- View FBT Profile
- View Questions on FBT

Q: Hi 5i, can you give me the names of 4 or 5 large cap pharmaceutical companies that are buyable now. Also I'm looking for 4 or 5 Biotech companies with one drug in the market making money and maybe something in the pipeline that looks like it has a good future? for example TGTX.

Read Answer Asked by Mark on January 09, 2025